AstraZeneca and Mitsubishi divisions collab on next-gen ADCs
AZ’s MedImmune and a Mitsubishi pharma subsidiary are set to collaborate on creating next-generation ADCs using pyrrolobenzodiazepine (PBD)-based warheads.
AZ’s MedImmune and a Mitsubishi pharma subsidiary are set to collaborate on creating next-generation ADCs using pyrrolobenzodiazepine (PBD)-based warheads.
English pharmacists are not free to dispense biosimilars in place of reference biologics, the country’s National Health Service says in its latest guidance.
Lonza has published a guide to clinical-grade induced pluripotent stem cell (IPSC) manufacture, addressing concerns around the derivation of cellular materials.
Air pollution increases the likelihood that people genetically predisposed to Alzheimer’s will develop the disease according to Mexican researchers.